What Is Squamous Metaplasia of the Cervix?

Squamous metaplasia of the cervix is a normal physiological process in which the delicate, single-layered columnar cells lining the inner cervical canal are gradually replaced by tougher, multi-layered squamous cells. It happens in virtually every woman of reproductive age and is not, on its own, a disease or a sign that something has gone wrong. The process takes place in a specific region of the cervix called the transformation zone, and while it is entirely benign, the actively changing tissue does have clinical significance because it is more vulnerable to HPV infection than mature, stable tissue.

Where It Happens and Why

The cervix has two main types of surface lining. The outer portion (ectocervix) that faces the vagina is covered in flat, layered squamous cells built to withstand an acidic environment. The inner cervical canal (endocervix) is lined with tall, mucus-producing columnar cells. Where these two cell types meet is called the squamocolumnar junction. The transformation zone is the band of tissue around that junction where columnar cells are actively being converted into squamous cells through metaplasia.

The location of the squamocolumnar junction shifts throughout a woman’s life. During puberty and pregnancy, rising estrogen causes the columnar lining to extend outward onto the ectocervix, a condition called ectopy or ectropion. That exposed columnar tissue is now sitting in the acidic vaginal environment, which it was not designed for. In response, small stem-like cells beneath the columnar layer begin to multiply and differentiate into squamous cells, gradually replacing the columnar lining with tissue better suited to the new conditions. This replacement process is squamous metaplasia. There is broad agreement among pathologists that the transformation zone is simply the area where this metaplasia has occurred or is occurring.¹

The process is most active during adolescence, the first pregnancy, and whenever hormonal shifts push the junction outward. After menopause, lower estrogen levels cause the junction to recede back into the canal, and metaplasia slows or stops. This is why young women typically have a larger, more visible transformation zone than older women.

The Reserve Cells That Drive the Process

Metaplasia does not happen by squamous cells migrating in from the sides. Instead, a distinct population of tiny cells sitting just beneath the columnar layer, called reserve cells, does the work. These reserve cells begin to proliferate and form a new layer underneath the existing columnar cells. As they multiply, they push upward, and the columnar cells on top are eventually shed. The new reserve cell progeny gradually mature into full squamous epithelium.

Research into the molecular markers of these reserve cells shows they already express certain proteins associated with squamous identity, particularly cytokeratins 5 and 17, even before the new squamous layer is fully formed.² In other words, these cells are primed to become squamous tissue; they just need the environmental cue to start. During immature metaplasia, the earliest phase, immunostaining shows CK17-positive reserve cells actively proliferating beneath the columnar surface, with the columnar cells above still negative for that marker.³ Once the process completes, the resulting mature squamous epithelium looks and functions like native squamous tissue.

The fact that reserve cells have the capacity to form a full stratified squamous layer is also what makes them a plausible target for HPV. Their ability to proliferate and differentiate into layered epithelium provides exactly the kind of cellular machinery that the virus hijacks to replicate.⁴

Why Active Metaplasia Makes Tissue Vulnerable to HPV

The transformation zone is where the vast majority of cervical cancers originate, and the reason traces back to the metaplastic process itself. When metaplasia is actively underway, the tissue is in a state of rapid cell division and remodeling. This creates conditions that HPV exploits. The virus needs access to basal cells (the bottom layer of the epithelium), which is easier when the tissue is immature and not yet fully layered. Active cell division also gives HPV a chance to integrate its DNA into the host genome as the cells replicate.

A study following about 200 young women (average age 17 at enrollment) over roughly four years found that the rate of active squamous metaplasia in the cervix was significantly associated with later acquisition of HPV 16. Women with more rapidly progressing metaplasia had a higher risk of picking up the virus. Interestingly, the mere presence of ectopy, the exposed columnar tissue itself, was not a significant risk factor. It was the active conversion process, not just the presence of columnar cells, that mattered.⁵

Laboratory work supports this picture. When researchers cultured primary cells from the transformation zone and exposed them to HPV 16, these cells were more susceptible to being immortalized by the virus compared to cells from fully mature tissue. Transformation zone cells and endocervical cells also appeared more susceptible to developing dysplastic (precancerous) patterns of growth when maintained in organotypic culture conditions.⁶

This is a critical distinction for understanding cervical cancer risk. Squamous metaplasia itself is not precancerous. But while it is happening, the tissue is in a window of heightened vulnerability. Once the metaplasia is complete and the squamous epithelium has fully matured, that vulnerability largely closes. This is one reason why cervical cancer risk is highest in younger women who are still undergoing active metaplasia and who are sexually active during that window.

When a Pap Smear Reports Squamous Metaplasia

Seeing “squamous metaplasia” or “squamous metaplastic cells present” on a Pap smear result often causes unnecessary worry. In reality, it is a reassuring finding. It confirms that the sample was taken from the transformation zone, which is where the sample should come from. A Pap smear that does not include transformation zone cells may have missed the very area most likely to harbor abnormal changes. So “metaplastic cells present” essentially means “your sample was collected correctly.”

There is, however, a diagnostic challenge that pathologists deal with behind the scenes. Immature squamous metaplasia, the early phase where the new squamous cells are still small and densely packed, can look strikingly similar under the microscope to high-grade cervical intraepithelial neoplasia, the precancerous changes known as CIN II or CIN III. Both show tightly packed cells with large nuclei relative to their cytoplasm. A pathologist who confuses one for the other could either miss a real precancer or, more commonly, trigger unnecessary follow-up procedures for a completely normal finding.

This is where molecular markers come in. Research has shown that a panel of proteins, including CK17, p63, and p16, can reliably distinguish immature metaplasia from CIN. In immature metaplasia, CK17 tends to be strongly positive in the basal and reserve cell layers, while p16 is absent or focal. In high-grade CIN driven by HPV, the pattern flips: p16 becomes strongly and diffusely positive (because HPV’s E7 protein disrupts the cell cycle in a way that causes p16 to build up), and CK17 expression differs.⁷ These markers give pathologists confidence when the microscopic appearance alone is ambiguous.

Metaplasia as a Broader Biological Pattern

Squamous metaplasia of the cervix is the most well-known example of metaplasia in the human body, but the process occurs in other tissues too. The bronchial airways, bladder, and esophagus can all undergo metaplasia in response to chronic irritation or environmental insult. In the esophagus, for instance, repeated acid reflux can cause the squamous lining to be replaced by columnar, intestinal-type tissue, a condition called Barrett’s esophagus, which is essentially the reverse of what happens in the cervix.

The general principle behind all metaplasia is the same: when one type of mature tissue is chronically exposed to conditions it was not built to handle, the body replaces it with a tissue type better suited to the new environment. This is an adaptive response, not an error. But across organ systems, metaplastic tissue carries an elevated risk of progressing to dysplasia and eventually cancer if the irritating stimulus persists. A review in Nature Reviews Cancer characterized metaplasia as universally a precursor to low-grade dysplasia, which can culminate in high-grade dysplasia and carcinoma.⁸ In the cervix, the irritating stimulus is the acidic vaginal pH, but the real danger comes from HPV entering the picture during the active remodeling window, not from the acid exposure itself.

This broader context helps explain why researchers describe the transformation zone as “fertile soil” for neoplastic development. It is not that the metaplastic cells are abnormal. It is that the process of tissue remodeling creates a transient environment where the normal safeguards against viral infection and abnormal cell growth are slightly weakened.

Nabothian Cysts and Other Physical Side Effects

As squamous metaplasia progresses, the new squamous tissue sometimes grows over the openings of mucus-producing glands that were part of the original columnar lining. When this happens, the gland’s secretions get trapped beneath the surface, forming a small, fluid-filled cyst called a nabothian cyst. These cysts are extremely common and are visible during a routine pelvic exam as smooth, round, whitish or yellowish bumps on the cervix.

Nabothian cysts are entirely benign and rarely cause symptoms. They can range from a few millimeters to about a centimeter in diameter. Occasionally, larger ones are noticed incidentally on ultrasound or MRI and cause momentary concern, but they require no treatment unless they are causing mechanical symptoms such as discomfort. They are simply a cosmetic byproduct of the metaplastic process, evidence that the squamous tissue did its job of resurfacing the cervix but sealed off a few glandular ducts in the process.

Does Anything Speed Up or Slow Down Metaplasia

Hormonal changes are the primary driver. Anything that increases estrogen exposure, such as puberty, pregnancy, or estrogen-containing contraceptives, tends to push the squamocolumnar junction outward, exposing more columnar tissue and setting the stage for more metaplasia. This is one reason why early age at first intercourse is a well-established risk factor for cervical cancer: a teenage cervix typically has a large, active transformation zone, and sexual exposure to HPV during that window is more likely to lead to persistent infection than the same exposure a decade later when the metaplasia has matured.

Chronic inflammation from infections such as bacterial vaginosis, chlamydia, or gonorrhea can also influence the local cervical environment in ways that promote or sustain metaplasia. Inflammation increases cell turnover and may make the metaplastic tissue more permeable to viral entry. That said, treating these infections does not reverse metaplasia that has already occurred; it simply removes one factor that may have been sustaining active remodeling.

Smoking is another environmental factor that affects cervical tissue. Carcinogenic metabolites from tobacco have been detected in cervical mucus, and smoking is associated with higher rates of CIN and cervical cancer. While the link is primarily through impaired immune surveillance against HPV rather than through accelerated metaplasia per se, it adds to the picture that the cervical transformation zone is a site where multiple environmental factors converge.

Immature Versus Mature Metaplasia

When pathologists describe squamous metaplasia, they typically classify it as immature or mature. The distinction matters clinically because the two stages look different under the microscope, behave differently during colposcopy, and carry different implications.

Immature squamous metaplasia consists of thin, loosely organized layers of cells that have not yet developed the full protective architecture of mature squamous epithelium. Under colposcopy, immature metaplasia can appear as a faintly white area after application of acetic acid (the vinegar solution used during the exam), which can mimic the appearance of a low-grade abnormality. This is one of the most common reasons for unnecessary biopsies in young women: the colposcopist sees acetowhite epithelium and biopsies it, only for pathology to report normal immature metaplasia.

Mature squamous metaplasia, by contrast, is indistinguishable from native squamous epithelium in most respects. The cells are fully stratified, the surface is smooth, and the tissue responds normally to colposcopic tests. Once metaplasia reaches this stage, the tissue no longer carries the heightened HPV vulnerability associated with the immature phase. For practical purposes, it is native squamous tissue now, just with a different developmental origin.

Atypical Squamous Metaplasia

Occasionally, pathologists encounter metaplastic tissue that does not look entirely normal but also does not meet the criteria for cervical intraepithelial neoplasia. This in-between category is sometimes called atypical squamous metaplasia, or atypical immature squamous metaplasia. The cells show some features that overlap with precancerous changes: slightly larger nuclei, mildly irregular architecture, or a subtle loss of normal maturation patterns.

Distinguishing atypical metaplasia from genuine CIN is one of the most debated areas in cervical pathology. The stakes are real: calling it CIN when it is actually atypical metaplasia means unnecessary procedures, while calling it metaplasia when it is actually CIN means a precancer gets missed. The biomarker panel discussed earlier, particularly the combination of CK17, p63, and p16, has proven useful for resolving ambiguous cases. Atypical metaplasia tends to be CK17-positive and p16-negative, while HPV-driven CIN tends to be p16-positive and shows a different pattern of CK17 expression.⁷ In cases where the staining pattern is typical for metaplasia, the woman can generally be reassured and followed with routine screening rather than being fast-tracked for treatment.

What Squamous Metaplasia Is Not

The most persistent misconception about squamous metaplasia is that it is a precancerous condition. It is not. It is a normal tissue adaptation, equivalent to the skin forming a callus in response to friction. The tissue is responding appropriately to its environment. What makes the transformation zone clinically important is not metaplasia itself but the fact that HPV can exploit the process while it is underway. If HPV never enters the picture, metaplasia proceeds to completion without any adverse consequence.

Another common confusion involves the term “transformation zone.” In everyday language, “transformation” sounds alarming, as though the tissue is transforming into something dangerous. In this context, the word simply means an area where one type of normal tissue is being replaced by another type of normal tissue. The transformation zone is a geographic region, not a pathological diagnosis. Every woman who has gone through puberty has one.

Finally, squamous metaplasia should not be confused with squamous intraepithelial lesion (SIL) or cervical intraepithelial neoplasia (CIN). These terms describe abnormal changes driven by HPV, where cells are proliferating in a disordered way and failing to mature properly. Metaplasia is orderly replacement. Dysplasia is disordered growth. They can occur in the same tissue, and one can follow the other if HPV gets involved, but they are fundamentally different processes with different cellular behaviors and different outcomes.